Latest News about Phase 1 Trial
Recent news which mentions Phase 1 Trial
See Why FDA Hit Red Light On Kura's Early-Stage Leukemia Trial
November 24, 2021
Tickers
KURA
From Benzinga
Aptevo Stock Rallies After Posting First Complete Remission In Early Acute Myeloid Leukemia Trial
November 23, 2021
Tickers
APVO
From Benzinga
Dermata's Aesthetic Improvement Candidate Fails To Impress - Read Why
November 19, 2021
Tickers
DRMA
From Benzinga
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
November 19, 2021
From Benzinga
Safety Signals Force Enanta To Stop EDP-721 HBV Program
November 19, 2021
Tickers
ENTA
From Benzinga
Plus Therapeutics' Targeted Radiotherapy Shows Encouraging Overall Survival In Brain Tumour Trial
November 18, 2021
Tickers
PSTV
From Benzinga
From Benzinga
Moderna Posts Interim Data From mRNA Triplet Program In Solid Tumors
November 15, 2021
From Benzinga
Agenus Posts Early Data For CTLA-4 Drug Candidate Across Tumor Types
November 12, 2021
Tickers
AGEN
From Benzinga
Freeline Therapeutics Touts Encouraging Data From Fabry Disease Program
November 10, 2021
Tickers
FRLN
From Benzinga
Yumanity Therapeutics Stock Plunges After Parkinson's Trial Data
November 10, 2021
Tickers
YMTX
From Benzinga
Terns' Potential NASH Candidate Shows Potent Liver Target Engagement
November 10, 2021
Tickers
TERN
From Benzinga
Takeda, Shattuck Labs Terminate Immuno-Oncology Pact
November 09, 2021
From Benzinga
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
November 09, 2021
From Benzinga
From Benzinga
From Benzinga
Moderna Scraps mRNA-Based Antibody Program Targeting Chikungunya Virus
November 04, 2021
Tickers
MRNA
From Benzinga
Equillium Reveals Early Safety Data For Itolizumab In Lupus Patients
November 02, 2021
Tickers
EQ
From Benzinga
Cabaletta Posts Cell Therapy Data From Third Cohort Of Autoimmune Skin Disorder Trial
November 01, 2021
Tickers
CABA
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.